Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

131 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2018-05-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are no recommendations and few studies on the monitoring of fragile patients in the oncological treatment, both on the organizational arrangements on its interest in the prevention of functional deterioration of the patient and adaptation of the potential cancer treatment.

The oncogériatrique evaluation being time-consuming, requiring the movement of these more or less frail elderly patients, it seems difficult to envisage repeated and systematic standardized geriatric assessments during cancer treatment. Geriatric fragility can be detected by telephone. Craven et al. has already assessed the telephone follow-up by a nurse in patients treated for cancer, but with the aim to detect toxicities of cancer treatment, patients are not very old (mean age 64.8 years).

External evaluation by the nurse coordinator of UCOG (Coordination Unit in geriatric oncology) not knowing the patients included avoids bias of subjectivity in the interrogation.

However the telephone monitoring, with the aim to evaluate the evolution of geriatric frailty, has not been specifically studied in the elderly population treated for cancer, while taking oncology load.

The investigators wish to study the feasibility and validity of telephone follow-up which could eventually be used routinely to identify patients requiring further medical consultation oncogériatrique.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)

NCT03261128

75 Years Old and More Cancer Chemotherapy

COMPLETED

Patient-Centered Care for the Older Adult With Hematologic Malignancy

NCT02359838

Hematologic Malignancy

COMPLETED NA

Geriatric Oncology Follow-up in the Alpine Valley

NCT03349229

Oncology Aging

UNKNOWN

Nursing Follow up in Geriatric Oncology : Tracking Time of Caregiver Exhaustion Risk

NCT02551965

Exhaustion Geriatric Disorder

UNKNOWN NA

Deployment of Teleconsulting in Geriatric Oncology for Older Patients

NCT05619731

Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Hematologic Malignancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nurse telephone contact

3 days of consultation, telephone follow-up of the patient by the nurse coordinator of the Geriatric Oncology Unit to validate

Group Type OTHER

Nurse telephone contact

Intervention Type OTHER

Nurse will contact patient 3 days before consultation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nurse telephone contact

Nurse will contact patient 3 days before consultation

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 70 years and older with cancer or hematologic malignancies;
* Faced benefit from cancer treatment (systemic treatment, curative radiotherapy) in one of the clinical sites;
* Addressed in onco-gériatric consultation in the usual routine care sector;
* Mastery of the French language;
* Patient affiliated to the social security system;
* Patient has given its written consent.

Exclusion Criteria

* Life expectancy \<3 months
* Inability to communicate by telephone (deafness, speech disorder, ..)
* Inability collection of written consent
* Group 4 SiO (International Society of Geriatric Oncology), Performance status (PS) 4
* initial MMSE (Mini-Mental State Examination) \<18/30
* oncological treatment envisaged: analgesic radiotherapy or exclusive decompressive, brain radiation therapy in toto
* Patient under guardianship

Minimum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No